(-)-Limonene

(-)-Limonene

SCHEMBL797520

C=C(C)C1CC=C(C)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
ALOX15 P16050 4/20 0.59
ALDH1A1 P00352 3/20 0.59
CYP1B1 Q16678 1/20 0.59
TSHR P16473 4/20 0.58
TRPA1 O75762 1/20 0.58
TP53 P04637 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 2/20 0.43
CNR1 P21554 1/20 0.39
CYP3A4 P08684 1/20 0.37
CHRNA7 P36544 1/20 0.37
STAT3 P40763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Limonene SCHEMBL22013 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL1164294 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
D-Limonene SCHEMBL3988306 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL233098 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL1871533 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL8829 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
D-Limonene SCHEMBL787931 1.00 LMNA (1.00) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL11163746 0.98 LMNA (0.96) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL2852625 0.98 LMNA (0.96) LMNAALOX15ALDH1A1CYP1B1TSHR
(-)-Limonene SCHEMBL22769867 0.98 LMNA (0.96) LMNAALOX15ALDH1A1CYP1B1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906351-B2 2,2′-furoin derivatives and use thereof to light skin MERCK PATENT GMBH (DE) 2014-12-09 US disclosed
EP-2616040-B1 2,2'-FUROIN DERIVATIVES AND THEIR USE FOR SKIN LIGHTENING MERCK PATENT GMBH (DE) 2014-10-22 EP disclosed
EP-2616040-A1 2,2'-FUROIN DERIVATIVES AND USE THEREOF TO LIGHTEN SKIN Merck Patent GmbH (DE) 2013-07-24 EP disclosed
US-20130164230-A1 2,2'-FUROIN DERIVATIVES AND USE THEREOF TO LIGHT SKIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-06-27 US disclosed
WO-2012034629-A1 2,2'-FUROIN DERIVATIVES AND USE THEREOF TO LIGHTEN SKIN MERCK PATENT GMBH (DE) 2012-03-22 WO disclosed
EP-0284563-B1 Milbemycin derivatives for combating parasites on livestock CIBA GEIGY AG (CH) 1994-06-15 EP disclosed
US-4973711-A Composition for controlling parasites in productive livestock CIBA-GEIGY CORPORATION (US) 1990-11-27 US disclosed
US-4871719-A MILBEMYCIN CIBA-GEIGY CORPORATION (US) 1989-10-03 US disclosed
EP-0284563-A2 Milbemycin derivatives for combating parasites on livestock CIBA-GEIGY AG (CH) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130164230-A1 2,2'-FUROIN DERIVATIVES AND USE THEREOF TO LIGHT SKIN TYR, ALDH1A2, MC1R LMNA 1329/4885ALOX15 125/4885ALDH1A1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.